ArticleCancer science2021

VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene-driven non-small-cell lung cancers.

Hiromi Watanabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.